NRSN icon

NeuroSense Therapeutics

9 hedge funds and large institutions have $694K invested in NeuroSense Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
IC
1
Ikarian Capital
Texas
$397K +$397K +100,000 New
Jane Street
2
Jane Street
New York
$173K +$173K +43,498 New
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$65K +$65K +10,000 New
BFM
4
Boothbay Fund Management
New York
$48K +$48K +12,170 New
UBS Group
5
UBS Group
Switzerland
$7K -$22.8K -6,134 -77%
FIA
6
FNY Investment Advisers
New York
$3K +$3K +1,000 New
TRCT
7
Tower Research Capital (TRC)
New York
$1K -$3.41K -1,023 -77%
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
-$184K -75,000 Closed
Citadel Advisors
9
Citadel Advisors
Florida
-$135K -55,119 Closed
WAM
10
Warberg Asset Management
Illinois
-$38K -15,501 Closed